Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 57
Filter
1.
Sex Transm Infect ; 2024 Jul 04.
Article in English | MEDLINE | ID: mdl-38964838

ABSTRACT

OBJECTIVES: Sexually transmitted infections (STIs) have markedly increased over the last decade in Spain, calling for prevention and control innovative approaches. While there is evidence indicating the effectiveness of self-sampling for STI diagnosis, no kits for this purpose have been authorised in Spain. METHODS: A prospective single-blind cross-sectional study carried out between November and December 2022 in an STI clinic in Madrid, Spain, to determine the validity, feasibility and acceptability of self-sampling kits used by non-healthcare professionals from vagina, pharynx, rectum and urethra to diagnose Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). Self-samples were compared with samples collected by healthcare professional (HC samples) and analysed by PCR. Frequency of CT and NG diagnosis by sample type was compared using McNemar's test for paired data. Sensitivity and specificity of self-samples for CT and NG diagnosis were also calculated. RESULTS: 306 self-samples from 51 participants were analysed. 80% were men with median age of 33 (IQR: 28-38) years. Self-samples and HC samples showed no significant statistical differences in CT and NG diagnosis. Self-samples had a sensitivity of 81% for CT and 93% for NG, with a specificity of 97% for CT and 95% for NG. More than 90% of participants had no difficulty understanding the kit instructions and 71% expressed high levels of satisfaction with the self-sampling kit. CONCLUSION: Self-sampling kits for CT and NG diagnosis can be safely and effectively used by non-healthcare professionals in Spain. National strategies for STI prevention and control should prioritise self-sampling strategies.

2.
Acta Derm Venereol ; 98(6): 556-562, 2018 Jun 08.
Article in English | MEDLINE | ID: mdl-29583157

ABSTRACT

The aim of this case-case study was to determine the differences between dysplastic and common naevus-associated melanomas (NAM) and de novo melanomas. A total of 1,021 prospectively collected patients with invasive cutaneous melanoma from an oncology referral centre were included in the study. Of these, 75.51% had de novo melanomas, 12.93% dysplastic NAM, and 11.56% common NAM. Dysplastic NAM, compared with de novo melanomas, were associated with intermittently photo-exposed sites, atypical melanocytic naevi, decreased tumour thickness, and presence of MC1R non-synonymous variants. Common NAM were more frequent on the trunk and of superficial spreading type. Comparison of dysplastic with common NAM showed significant difference only with regard to mitoses. Both subtypes of NAM shared less aggressive traits than de novo melanomas, albeit with no significant differences in survival after multivariate adjustment. In conclusion, NAM present with less aggressive traits, mostly due to a greater awareness among patients of changing moles than due to their intrinsic biological characteristics.


Subject(s)
Dysplastic Nevus Syndrome/pathology , Melanoma/pathology , Skin Neoplasms/pathology , Adult , Aged , Disease Progression , Disease-Free Survival , Dysplastic Nevus Syndrome/mortality , Dysplastic Nevus Syndrome/therapy , Female , Genetic Predisposition to Disease , Humans , Kaplan-Meier Estimate , Male , Melanoma/mortality , Melanoma/therapy , Middle Aged , Mutation , Phenotype , Proportional Hazards Models , Receptor, Melanocortin, Type 1/genetics , Retrospective Studies , Risk Factors , Skin Neoplasms/mortality , Skin Neoplasms/therapy , Spain/epidemiology , Time Factors
6.
J Cutan Pathol ; 43(5): 456-60, 2016 May.
Article in English | MEDLINE | ID: mdl-26968131

ABSTRACT

Langerhans cell histiocytosis (LCH) and juvenile xanthogranuloma (JXG) are thought to originate from a common stem cell precursor, with divergent differentiation under different microenvironmental conditions. We describe an exceptional case of multiple cutaneous lesions in a 10-year-old boy, in which the coexistence of both LCH and JXG cell populations is found in every single lesion. The presence of Birbeck granules and CD207 (langerin) immunostaining in the LCH component would argue against the diagnosis of indeterminate cell histiocytosis (ICH). This unique case gives additional support to the hypothesis of a potentially common histogenesis for LCH and JXG.


Subject(s)
Antigens, CD/metabolism , Histiocytosis, Langerhans-Cell , Lectins, C-Type/metabolism , Mannose-Binding Lectins/metabolism , Skin , Xanthogranuloma, Juvenile , Child , Histiocytosis, Langerhans-Cell/complications , Histiocytosis, Langerhans-Cell/metabolism , Histiocytosis, Langerhans-Cell/pathology , Humans , Male , Skin/metabolism , Skin/pathology , Xanthogranuloma, Juvenile/complications , Xanthogranuloma, Juvenile/metabolism , Xanthogranuloma, Juvenile/pathology
9.
Int J STD AIDS ; 35(8): 648-650, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38507781

ABSTRACT

The occurrence of cysts and papulopustules along the midline penile raphe, as a complication of gonococcal urethritis, is considered an exceptional presentation. These lesions are related to developmental abnormalities in the fusion of the lower portion of the ventral abdominal wall during embryogenesis, which create small pathways along the raphe of the penis, prone to secondary infection in the presence of gonococcal urethritis. We present the case of a 25-year-old male who experienced these lesions twice, coinciding with two separate episodes of gonococcal urethritis following unprotected sex. Treatment with intramuscular ceftriaxone resolved both the urethritis and cystic lesions.


Subject(s)
Anti-Bacterial Agents , Ceftriaxone , Gonorrhea , Neisseria gonorrhoeae , Penis , Urethritis , Humans , Male , Gonorrhea/diagnosis , Gonorrhea/drug therapy , Adult , Ceftriaxone/therapeutic use , Ceftriaxone/administration & dosage , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Urethritis/microbiology , Urethritis/drug therapy , Urethritis/diagnosis , Neisseria gonorrhoeae/isolation & purification , Penis/microbiology , Treatment Outcome
10.
Int J STD AIDS ; 35(2): 155-157, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37852285

ABSTRACT

Tyson's glands are sebaceous glands located on each side of the frenulum that communicate with the preputial sac, and their inflammation can be an infrequent complication of urethritis. We describe a rare case that presented with urethral discharge and parafrenular swelling with mucopurulent discharge a week after an unprotected sexual encounter. The patient was empirically treated with 500 mg of ceftriaxone intramuscularly and 100 mg of doxycycline every 12 h for 14 days with symptomatic resolution. The urethral swab culture and the urine polymerase chain reaction (PCR) were negative for Neisseria gonorrhoeae and Chlamydia trachomatis, therefore, and given the response to treatment, nongonococcal tysonitis was diagnosed.


Subject(s)
Chlamydia Infections , Gonorrhea , Urethritis , Humans , Chlamydia Infections/diagnosis , Urethritis/diagnosis , Urethritis/drug therapy , Urethritis/etiology , Chlamydia trachomatis , Neisseria gonorrhoeae/genetics , Doxycycline/therapeutic use , Gonorrhea/complications , Gonorrhea/diagnosis , Gonorrhea/drug therapy
11.
Contact Dermatitis ; 69(2): 78-85, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23869727

ABSTRACT

BACKGROUND: Iodopropynyl butylcarbamate (IPBC) is a preservative that may cause contact allergy. The first cases were reported in 1997, and IPBC is currently included in our extended European baseline series in Denmark. OBJECTIVES: To assess trends during the period 2000-2011 concerning IPBC allergy in Denmark, and to address the question of the significance of concomitant reactions to the thiuram mix. PATIENTS/MATERIALS/METHODS: Nine thousand seven hundred and fifty-five (6449 female; 3306 male) patients were patch tested with IPBC and the European baseline series at Gentofte Hospital during 2000-2011. The results were registered in an anonymized database, and analyzed with spss™. RESULTS: Fifty-four cases of IPBC contact allergy were detected. A significant rising trend during 2000-2011 was observed, with no significant changes during 2006-2011. MOAHLFA index analysis showed that IPBC contact allergy was, in our cohort, significantly more prevalent among male patients, occupational, related to hand eczema, and more frequent among patients over 40 years old. A significant relationship between IPBC and thiuram mix allergy was found. CONCLUSIONS: IPBC continues to be among the less frequent allergens. A 0.2% concentration in patch testing has contributed to the diagnosis of more sensitizations to this substance. Further studies are needed to clarify the reason for the over-representation of thiuram allergy in patients sensitized to IPBC.


Subject(s)
Carbamates/adverse effects , Dermatitis, Allergic Contact/epidemiology , Adult , Age Distribution , Cohort Studies , Denmark/epidemiology , Dermatitis, Allergic Contact/etiology , Eczema/epidemiology , Female , Hand Dermatoses/epidemiology , Humans , Male , Middle Aged , Multivariate Analysis , Patch Tests , Prevalence , Sex Distribution
12.
Nutrients ; 15(11)2023 May 30.
Article in English | MEDLINE | ID: mdl-37299523

ABSTRACT

Increasing evidence from experimental animal nutrition studies suggests that vitamin D may potentially influence apoptosis and tumor-associated angiogenesis, reduce the initiation of carcinogenesis, and delay the multiplication and proliferation of tumor cells [...].


Subject(s)
Vitamin D , Vitamins , Animals , Carcinogenesis , Neovascularization, Pathologic
13.
Tob Prev Cessat ; 9: 37, 2023.
Article in English | MEDLINE | ID: mdl-38111804

ABSTRACT

INTRODUCTION: The study aimed to assess the impact of a new intervention proposal involving students, teachers, and parents on smoking prevalence in secondary school adolescents. METHODS: A quasi-experimental study was conducted, in which the response to a preventive multi-personal intervention model (intervention) against tobacco consumption was compared with a standard anti-smoking activity carried out by the local government administration (control). The study was carried out during the 2017-2018 academic year. The study population included 306 students (intervention 151, control 155) with a mean age of 13.4 years. The model involved the parents, the students (aged 15-17 years), and the teachers. The primary outcome was the change in smoking status one year after the intervention. RESULTS: The percentage of non-smokers increased from 84.1% to 88.7% in the intervention group and remained almost unchanged among controls (89.3% vs 89.9%). After one year, there was an increase in the prevalence of non-smokers of 4.6% and a decrease in the prevalence of smokers of 4.7% among students who received the multi-personal intervention, whereas changes among controls were almost negligible (there was in fact a slight increase in the prevalence of smokers of 0.9%). The students who received the intervention smoked less or quit smoking more than those in the control group (OR=0.135; 95% CI: 0.019-0.973, p=0.047). CONCLUSIONS: The multi-personal model developed in the study with the participation of teachers and parents focused on students was feasible, and effectively reduced the prevalence of smoking among high school adolescents.

14.
Nutrients ; 15(8)2023 Apr 07.
Article in English | MEDLINE | ID: mdl-37111028

ABSTRACT

BACKGROUND: The impact of vitamin D supplementation on cardiovascular outcomes and mortality risk reduction remains unclear due to conflicting study findings. METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs), published between 1983 and 2022, that reported the effect of vitamin D supplementation in adults versus placebo or no treatment on all-cause mortality (ACM), cardiovascular mortality (CVM), non-cardiovascular mortality (non-CVM), and cardiovascular morbidities. Only studies with a follow-up period longer than one year were included. The primary outcomes were ACM and CVM. Secondary outcomes were non-CVM, myocardial infarction, stroke, heart failure, and major or extended adverse cardiovascular events. Subgroup analyses were performed according to low-, fair- and good-quality RCTs. RESULTS: Eighty RCTs were assessed, including 82,210 participants receiving vitamin D supplementation and 80,921 receiving placebo or no treatment. The participants' mean (SD) age was 66.1 (11.2) years, and 68.6% were female. Vitamin D supplementation was associated with a lower risk of ACM (OR: 0.95 [95%CI 0.91-0.99] p = 0.013), was close to statistical significance for a lower risk of non-CVM (OR: 0.94 [95%CI 0.87-1.00] p = 0.055), and was not statistically associated with a lower risk of any cardiovascular morbi-mortality outcome. Meta-analysis of low-quality RCTs showed no association with cardiovascular or non-cardiovascular morbi-mortality outcomes. CONCLUSIONS: The emerging results of our meta-analysis present evidence that vitamin D supplementation appears to decrease the risk of ACM (especially convincing in the fair- and good-quality RCTs), while not showing a decrease in the specific cardiovascular morbidity and mortality risk. Thus, we conclude that further research is warranted in this area, with well-planned and executed studies as the basis for more robust recommendations.


Subject(s)
Myocardial Infarction , Adult , Female , Humans , Aged , Male , Cause of Death , Randomized Controlled Trials as Topic , Myocardial Infarction/drug therapy , Vitamin D/therapeutic use , Dietary Supplements
15.
Dermatol Online J ; 18(9): 15, 2012 Sep 15.
Article in English | MEDLINE | ID: mdl-23031382

ABSTRACT

Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). This antibody, in combination with other antineoplastic agents, is currently used to treat various neoplasms, including colorectal, lung, breast, kidney cancer, and glioblastoma. It is also being used as an off-label intravitreal agent in the treatment of proliferative (neovascular) eye diseases. We report the development of a skin rash with two different patterns in a patient with a hemangiopericytoma of the meninges, a rare aggressive sarcoma, who was treated with repeated intravenous injections of bevacizumab.


Subject(s)
Acneiform Eruptions/etiology , Antibodies, Monoclonal, Humanized/adverse effects , Antineoplastic Agents/therapeutic use , Bone Neoplasms/drug therapy , Hemangiopericytoma/drug therapy , Liver Neoplasms/drug therapy , Meningeal Neoplasms/drug therapy , Acneiform Eruptions/drug therapy , Adult , Anti-Bacterial Agents/therapeutic use , Bevacizumab , Bone Neoplasms/secondary , Hemangiopericytoma/radiotherapy , Hemangiopericytoma/surgery , Humans , Liver Neoplasms/secondary , Lung Neoplasms/drug therapy , Lung Neoplasms/secondary , Male , Meningeal Neoplasms/pathology , Meningeal Neoplasms/radiotherapy , Meningeal Neoplasms/surgery , Neovascularization, Pathologic/drug therapy , Treatment Outcome
16.
Biomedicines ; 10(7)2022 Jul 02.
Article in English | MEDLINE | ID: mdl-35884885

ABSTRACT

Cutaneous melanoma is one of the most aggressive and deadliest cancers in human beings due to its invasiveness and other factors. Histopathological analysis is crucial for a proper diagnosis. Optical tissue clearing is a novel field that allows 3D image acquisition of large-scale biological tissues. Optical clearing and immunolabeling for 3D fluorescence imaging has yet to be extensively applied to melanoma. In the present manuscript, we establish, for the first time, an optical clearing and immunostaining procedure for human melanoma and human cell line-derived melanoma xenograft models using the CUBIC (clear, unobstructed brain imaging cocktails) technique. We have successfully cleared the samples and achieved 3D volumetric visualization of the tumor microenvironment, vasculature, and cell populations.

17.
Nutrients ; 13(12)2021 Nov 28.
Article in English | MEDLINE | ID: mdl-34959844

ABSTRACT

BACKGROUND: The current vitamin D deficiency epidemic is accompanied by an increase in endemic skin cancer. There are still multiple controversies. This review aims to give practical recommendations regarding vitamin D among people at risk or with a personal history of skin cancer. METHODS: Narrative review including human research articles published between 2011 and 2021, elaborated bearing in mind an epidemiological, patient-centered approach. RESULTS: Ultraviolet (UV) exposure (neither artificial nor natural) is not the ideal source to synthesize vitamin D. There is conflicting epidemiological evidence regarding vitamin D, non-melanoma skin cancer (NMSC), and cutaneous melanoma (CMM), confounded by the effect of sun exposure and other factors. CONCLUSIONS: Current evidence is controversial, and there are no widely applicable strategies. We propose three practical recommendations. Firstly, sun protection recommendations should be kept among people at risk or with a personal history of skin cancer. Secondly, vitamin D should preferably be sourced through diet. In patients with melanoma or at risk of cutaneous cancer, serum vitamin D checks are warranted to detect and avoid its insufficiency.


Subject(s)
Melanoma/epidemiology , Patient-Centered Care/trends , Skin Neoplasms/epidemiology , Vitamin D Deficiency/complications , Vitamin D/blood , Humans , Melanoma/etiology , Skin/radiation effects , Skin Neoplasms/etiology , Sunlight/adverse effects , Ultraviolet Rays/adverse effects , Vitamin D Deficiency/blood
18.
Dermatopathology (Basel) ; 8(3): 446-449, 2021 Sep 18.
Article in English | MEDLINE | ID: mdl-34563038

ABSTRACT

A case of a purely eccrine nevus in an adolescent patient presenting with focal hyperhidrosis on an area comprising the left forearm and the dorsal aspect of the left hand is described. No clinically evident lesions were identifiable. Dermatopathologic findings were subtle, showing only a slight increase in the number of eccrine glands. Clinicopathological correlation was paramount to achieve the diagnosis.

19.
Article in English, Spanish | MEDLINE | ID: mdl-33745892

ABSTRACT

This article, part of a the series on safety in dermatologic procedures, covers the diagnosis, prevention, management, and treatment of 3 situations or conditions. The first condition we address is anaphylaxis, an uncommon but severe and potentially fatal reaction that must be recognized quickly so that urgent management coordinated with an anesthesiologist can commence. The second is the vasovagal reaction, which is the most common complication in dermatologic surgery. This event, which occurs in 1 out of every 160 procedures, usually follows a benign course and resolves on its own. However, in patients susceptible to vasovagal reactions, syncope may lead to asystole and cardiac arrest. The third is acute hyperventilation syndrome, which is an anomalous anxiety-related increase in breathing rate beyond metabolic requirements. Brief practical recommendations for managing all 3 events are included.

SELECTION OF CITATIONS
SEARCH DETAIL